Mutations detected by immunohistochemical analysis included 22.7% (L858</span>R, 4/22; exon 19 deletion, 1/22) in AIS and 42.9% (L858R, 4/21; exon 19 deletion, 5/21) in MIA.
Mutations detected by immunohistochemical analysis included 22.7% (L858</span>R, 4/22; exon 19 deletion, 1/22) in AIS and 42.9% (L858R, 4/21; exon 19 deletion, 5/21) in MIA.
Mutations detected by immunohistochemical analysis included 22.7% (L858</span>R, 4/22; exon 19 deletion, 1/22) in AIS and 42.9% (L858R, 4/21; exon 19 deletion, 5/21) in MIA.